United States · 
Who invested in Geneos Therapeutics?
Geneos Therapeutics's investors include Korea Investment Partners and Santé Ventures/ Inovio.
20192020202120222023
$11MSeries A$5.0MSeries A
United States · Series A startup
Who invested in Geneos Therapeutics
Funding summaryUpdated 26 Oct 2026
$16Mraised across 2 rounds since 2019, from 2 sources
$11MSeries A$5.0MSeries A
- Latest round
- Series A, $5.0MSept 2023
- Biggest round
- $11MSeries A · Feb 2019
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $11M Feb 2019
- Biggest round
- $11M Series A · Feb 2019
- Between rounds
- 4.5 years from the last two
The rounds
- Sept 2023
- Feb 2019Series A$11M1 new
- Santé Ventures/ Inovio
Reported by FinSMEsSEC filing: $4.5M sold, first sale Feb 2019
Founders and team
From Geneos Therapeutics's own website and the SEC filings it signed: 2 on the team.
- Federica O’BrienPosition: Consulting Chief Financial Officer
- Niranjan Y. SardesaiExecutive Officer, Directori
On the board, as filediCasey Y. CunninghamJames Y. EadieLaurent Y. HumeauSamuel Y. BroderSangwoo Y. LeeTed Y. Fjallman
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Santé Ventures/ Inoviono record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Geneos Therapeutics
How much has Geneos Therapeutics raised?
Geneos Therapeutics has raised $16M across 2 rounds since 2019.
When did Geneos Therapeutics last raise?
Geneos Therapeutics's most recent round was a Series A of $5.0M in Sept 2023.
What was Geneos Therapeutics's biggest round?
Geneos Therapeutics's largest round on record is $11M (Series A), in Feb 2019.
Who backed Geneos Therapeutics first?
Geneos Therapeutics's first round on record, in Feb 2019, was backed by Santé Ventures/ Inovio.
What stage is Geneos Therapeutics at?
Geneos Therapeutics's latest named round is a Series A, in Sept 2023.
Where is Geneos Therapeutics based?
Geneos Therapeutics is based in the United States.
Companies like Geneos Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.